Lyara Therapeutics is pioneering a new era of therapeutic discovery by focusing on the genomic traits that protect, not just predispose. Through cross-disciplinary alliances and deep rare variant mapping, we unlock new biological insights that have potential to fuel precision therapies. Our mission is to shift the focus from disease prediction to resilience, opening new frontiers for preventive, personalized and protective medicine.
Driven by a pursuit of excellence and a commitment to making the most of every possibility, we recognize that health is not just the absence of illness it is the ability to endure. Even in the most challenging moments, we believe in the power of resilience, unhindered by inherited or imposed limitations.
Our Services
Genetic Variant Discovery
We identify rare and protective genetic variants with potential relevance in human health, disease resistance and future therapeutic development.
Genomic Advisory & Insight
We are developing curated insights and advisory based on unique genetic findings for researchers, biotech firms and licensing partners seeking new genomic leads.
Research-Ready Data Curation
Our genetic data is organized to support further investigation by labs, pharmaceutical companies and genomic innovators.
Innovation in Health & Resilience
Our focus is on rare variants with possible roles in cognitive resilience, immune function and aging for long term health impact.
Licensing Ready IP Platforms
We are building toward non-exclusive and exclusive licensing frameworks for validated genomic sequences with functional significance.
Join the Club
Join our email list and get access to news exclusive to our subscribers.